Precipio Expands ICE-COLD PCR Lung Cancer Mutation Detection Offering
New kit examines most relevant EGFR exons that affect therapeutic decisions for lung cancer patients.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Lung Cancer |
New kit examines most relevant EGFR exons that affect therapeutic decisions for lung cancer patients.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Research |
Independent study data show noninvasive test could eliminate the biopsy needle and reduce both patient anxiety and costs.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Research |
Partners to conduct first study using ctDNA-based minimal residual disease assessment for immunotherapy in the adjuvant non-small cell lung cancer setting.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Lung Cancer |
FDA approval allows use of the Therascreen EGFR RGQ PCR kit as a companion diagnostic for Pfizer’s Vizimpro (dacomitinib) in patients with non-small cell lung cancer.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Lung Cancer, Melanoma, Software |
The panel accurately and sensitively detects more than 1,600 variants of clinical significance.
Read More